Acadia Pharmaceuticals (ACAD) Other Non-Current Assets (2010 - 2026)

Acadia Pharmaceuticals' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $3.9 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 55.21% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $3.9 million (down 55.21% YoY), while the FY2025 annual figure was $7.8 million, down 10.55% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $3.9 million, down from $7.8 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $8.8 million in Q3 2024, with the low at $2.3 million in Q2 2025.
• The 5-year median for Other Non-Current Assets is $5.8 million (2022), against an average of $6.1 million.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets surged 86.13% in 2022, then sank 65.86% in 2025.
• Acadia Pharmaceuticals' Other Non-Current Assets stood at $5.8 million in 2022, then changed by 0.0% to $5.8 million in 2023, then jumped by 51.99% to $8.8 million in 2024, then declined by 10.55% to $7.8 million in 2025, then slumped by 49.93% to $3.9 million in 2026.
• Business Quant data shows ACAD's Other Non-Current Assets at $3.9 million in Q1 2026, $7.8 million in Q4 2025, and $3.0 million in Q3 2025.